Regular updates related to sourcing and the management of health products are available on this page.
-
13 August 2024
TB Ag Skin test (Cy-Tb) for Mycobacterium tuberculosis infection diagnosis manufactured by Serum Institute of India Pvt. Ltd. (SIIPL) recently recommended for use by Expert Review Panel
-
15 July 2024
Opportunity for Evaluation of Pharmaceutical Products – Antituberculosis Medicines
The Global Fund invites manufacturers of pharmaceutical products to submit an Expression of Interest (EoI) to have their products evaluated by the Expert Review Panel for pharmaceutical products (ERP). This evaluation will focus particularly on Antit... -
24 April 2024
New Quality Assurance Policy on Vector Control Products and Related Equipment
This new policy describes the main standards and requirements for Principal Recipients purchasing and deploying malaria vector control products through Global Fund resources. -
16 April 2024
Post-market surveillance of insecticide-treated nets
-
12 February 2024
Opportunity for Evaluation of Pharmaceutical Products – Antituberculosis Medicines
-
24 January 2024
Revised Quality Assurance Policies for Pharmaceuticals and Medical Devices (including In Vitro Diagnostics) and Core Personal Protective Equipment
To respond to the changing regulatory environment and enhance equitable access to quality assured health products, the Global Fund has updated its Quality Assurance Policy for Pharmaceuticals and Quality Assurance Policy for Medical Devices (includin...